BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 4811478)

  • 1. Cefazolin vs cephalothin and cephaloridine. A comparison of their clinical pharmacology.
    Regamey C; Gordon RC; Kirby WM
    Arch Intern Med; 1974 Mar; 133(3):407-10. PubMed ID: 4811478
    [No Abstract]   [Full Text] [Related]  

  • 2. Cephaloridine versus cephalothin: relation of the kidney to blood level differences after parenteral administration.
    Tuano SB; Brodie JL; Kirby WM
    Antimicrob Agents Chemother (Bethesda); 1966; 6():101-6. PubMed ID: 5985234
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative serum levels and urinary recovery of cefazolin, cephaloridine, and cephalothin in man.
    Cahn MM; Levy EJ; Actor P; Pauls JF
    J Clin Pharmacol; 1974 Jan; 14(1):61-6. PubMed ID: 4588120
    [No Abstract]   [Full Text] [Related]  

  • 4. [Body fluid concentration of parenterally administered cephalosporin C derivatives].
    Seiga K; Yamaji K; Sugiyama Y
    Jpn J Antibiot; 1972 Aug; 25(4):233-8. PubMed ID: 4539470
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of parenteral sodium cephalexin in comparison with cephalothin and cefazolin.
    Regamey C; Libke RD; Clarke JT; Kirby WM
    Infection; 1974; 2(3):132-6. PubMed ID: 4415038
    [No Abstract]   [Full Text] [Related]  

  • 6. Cefazolin, a new semisynthetic cephalosporin antibiotic. 3. Absorption, excretion and tissue distribution in parenteral administration.
    Nishida M; Matsubara T; Murakawa T; Mine Y; Yokota Y; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1970 Apr; 23(4):184-94. PubMed ID: 5423363
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics of biliary excretion of cefazolin and other cephalosporins with reference to the relationship between serum levels and administration conditions.
    Nishida M; Murakawa T; Matsubara T; Kohno Y; Yokota Y
    Chemotherapy; 1976; 22(1):30-6. PubMed ID: 1253628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cephazolin: pharmacology compared with that of 2 other cephalosporins].
    Guibert J; Lavarde M; Goldstein F
    Nouv Presse Med; 1974 Apr; 3(0):19-20. PubMed ID: 4837110
    [No Abstract]   [Full Text] [Related]  

  • 9. Binding of cephalothin, cephaloridine and cefazolin to human serum proteins.
    Miyake Y; Ebata M
    J Antibiot (Tokyo); 1976 Jun; 29(6):667. PubMed ID: 950323
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on chemotherapy during the perinatal period with special reference to such derivatives of cephalosporin C as cefazolin, cephaloridine and cephalothin.
    Fukada M
    Jpn J Antibiot; 1973 Jun; 26(3):197-214. PubMed ID: 4542543
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cefazolin, a new broad-spectrum antibiotic (author's transl)].
    Simon C; Malerczyk V; Brahmstaedt E; Toeller W
    Dtsch Med Wochenschr; 1973 Dec; 98(51):2448-50. PubMed ID: 4767675
    [No Abstract]   [Full Text] [Related]  

  • 12. Distribution of some newer antibiotics within the kidney interstitium: a therapeutic consideration in pyelonephritis.
    Cockett AT; Moore RS; Roberts AP
    Invest Urol; 1967 Nov; 5(3):250-9. PubMed ID: 6073633
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of cefazolin compared with four other cephalosporins.
    Kirby WM; Regamey C
    J Infect Dis; 1973 Oct; 128():Suppl:S341-6. PubMed ID: 4744015
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the pharmacokinetics of cefoxitin, cefuroxime, cephaloridine and cephalothin using subcutaneous tissue cages.
    Rylander M; Holm SE; Norrby R; Brorson JE
    Scand J Infect Dis Suppl; 1978; (13):52-7. PubMed ID: 278147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary tract excretion of cefazolin, cephalothin, and cephaloridine in the presence of biliary tract disease.
    Ratzan KR; Ruiz C; Irvin GL
    Antimicrob Agents Chemother; 1974 Oct; 6(4):426-31. PubMed ID: 4157339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cephalosporins from the clinical viewpoint].
    Regamey C
    Int J Clin Pharmacol Biopharm; 1975 Mar; 11(2):93-102. PubMed ID: 1095504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of cefazolin, cephaloridine, and cephalothin by methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus.
    Regamey C; Libke RD; Engelking ER; Clarke JT; Kirby MM
    J Infect Dis; 1975 Mar; 131(3):291-4. PubMed ID: 1039311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of absorption and excretion of cefazolin with cephalothin and cephapirin.
    Shimizu T
    Jpn J Antibiot; 1975 Aug; 28(4):542-8. PubMed ID: 1160145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of parenteral ampicillin and cephalosporins in late pregnancy.
    Stewart KS; Shafi M; Andrews J; Williams JD
    J Obstet Gynaecol Br Commonw; 1973 Oct; 80(10):902-8. PubMed ID: 4757497
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacodynamics of cephaloridine and cephalothin combined with sulfalene in rabbits].
    Bobrov VI; Beletskaia GT; Iakovlev VP
    Antibiotiki; 1984 Nov; 29(11):823-5. PubMed ID: 6524880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.